How big is the Immunoglobulin Market | Size, Trends, and Future Outlook 2025

Code: MTA6915 Publication Date: Jul 2025

How big is the Immunoglobulin Market?

According to 6Wresearch internal database and industry insights, the Global Immunoglobulin Market was valued at USD 13 Billion in 2024 and is expected to reach USD 18.68 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).

The market growth is driven by the rising prevalence of immunodeficiency disorders, increasing geriatric population, and growing awareness and diagnosis of neurological and autoimmune diseases.

Key Growth Drivers of the Immunoglobulin Market

  • Rising prevalence of primary and secondary immunodeficiency disorders
  • Increasing use in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Growing aging population with weakened immune systems
  • Increasing demand for plasma-derived therapies
  • Government support and favorable reimbursement policies for immunoglobulin therapies

Immunoglobulin Market Trends

The immunoglobulin market is seeing robust growth as advancements in plasma fractionation and purification processes improve product safety and efficacy. There is an increasing trend toward subcutaneous immunoglobulin (SCIG) administration, preferred for its convenience and reduced hospital visits. Innovations in delivery devices and self-infusion techniques are expanding home care use. Moreover, the market is benefiting from an increasing diagnosis rate for autoimmune and rare diseases, further fueling demand.

Emerging Developments in the Immunoglobulin Market

Immunoglobulin market is experiencing creation of recombinant immunoglobulin products aimed of diminishing dependency on plasma donate. More companies are increasing their outlets where plasma is collected. Machine learning and AI is applied to better select patients and monitor their available therapies. New regulatory regimes are in place which expedite approvals on innovation of new formulations of immunoglobulins. Asia-Pacific region is becoming a hotspot because of the increment of investments and exposure on healthcare.

Major Companies in the Immunoglobulin Market

  • CSL Behring
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Kedrion Biopharma Inc.
  • Octa pharma AG
  • LFB Group
  • Biotest AG
  • BDI Pharma
  • ADMA Biologics, Inc.
  • China Biologic Products Holdings Inc.

How big is the Immunoglobulin Market : FAQ's

It was valued at USD 13 Billion in 2024 and is projected to reach USD 18.68 Billion by 2031.
The immunoglobulin market is expected to grow at a CAGR of 5.60% from 2025 to 2031.
Rising immunodeficiency cases, aging population, and expanding use in neurological diseases.
Used in treating immunodeficiency disorders, autoimmune diseases, and neurological conditions.
North America dominates, with Asia-Pacific showing the fastest growth due to increasing healthcare infrastructure.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All